Forum - Read Topic Dupuytren's Disease Patient Discussion Forum - Topic: "Fasciotomy vs.
Topical corticosteroids for atopic dermatitis - [Medication] - Quest Diagnostics Patient Health Library Topic Contents - Examples - How It Works - Why It Is Used - How Well It Works - Side Effects - What To Think About - References Topical corticosteroids for atopic dermatitis - [Medication] - Quest Diagnostics Patient Health Library Topical corticosteroids for atopic dermatitis - [Medication] - Quest Diagnostics Patient Health Library anti-itch medications, antipruritic medications,...
http://www.fda.gov/cder/orange/appendix_a.txt 2, BUTABARBITAL SODIUM SARISOL, BUTABARBITAL SODIUM APPENDIX A PRODUCT NAME INDEX SATRIC, METRONIDAZOLE SCABENE, LINDANE SCANDONEST L, LEVONORDEFRIN SCANDONEST PLAIN, MEPIVACAINE HYDROCHLORIDE SCLEROSOL, TALC SCRUBTEAM SURGICAL SPONGEBRUSH, HEXACHLOROPHENE SEASONALE, ETHINYL ESTRADIOL SECOBARBITAL SODIUM, SECOBARBITAL SODIUM SECONAL SODIUM, SECOBARBITAL SODIUM SECREFLO, SECRETIN...
Alefacept (Amevive) Clinical Review page 25
author: CBER FDA
subject: dob062703
ANDA 75-338 ANDA 75- 338 February 9, 2001 Stiefel Laboratories, IncClobetasol Propionate Cream USP, 0.05%
author: CDER User
ANDA 75-338 page 1
author: CDER User
Prescription and OTC Drug Product List October 1997 Prescription and Over-the-Counter Drug Product List - 17th Edition Cumulative Supplement Number 10: Jan '97 - Oct '97 [ Prescription - OTC ] ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE CAPSULE; ORAL OXYCODONE AND ACETAMINOPHEN TABLET;...
Prescription and OTC Drug Product List 12/1998 Prescription and Over-the-Counter Drug Product List - 18th Edition Cumulative Supplement Number 12: December 1998 [ Prescription - OTC ] ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST - ADD - ABACAVIR SULFATE ALBUTEROL SULFATE - ADD - SOLUTION; ORAL SOLUTION; INHALATION - ADD - ZIAGEN ALBUTEROL SULFATE - ADD - + GLAXO WELLCOME EQ 20MG BASE/ML N20978 001 - ADD - @ COPLEY PHARM...
ANDA 75-363 ANDA 75- 363 December 29, 2000 Thames Pharmacal Co., IncClobetasol Propionate Topical Solution USP, 0.05%
author: CDER User
ANDA 75-363 page 1
author: CDER User
75279.AP.DOC page 1
author: Unknown
75430.AP.DOC ANDA 75- 430 May 26, 1999 Altana IncClobetasol Propionate Cream USP, 0.05%, (Emollient)
author: Unknown
75430.AP.DOC page 2
author: Unknown
H: 25.PDF ANDA 75- 325 December 24, 1998 Healthpoint, LtdClobetasol Propionate Cream, [Emollient]), 0...
author: Unknown
H: 25.PDF page 1
author: Unknown
DDPA July 1995 74-477 CAPTOPRIL HALLMARK PHARMA CAPTOPRIL 31-JUL-95 (TABLET) SOMERSET, NJ 12.5MG 08873 25MG 50MG 100MG (ANGIOTENSIN CONVERTING ENZYME INHIBITOR) ***LABELING SUPPLEMENTS TO ORIGINAL NDAs*** 17-087 ETHRANE OHMEDA ENFLURANE 05-JUL-95 (LIQUID) LIBERTY CORNER, NJ 99.9% 07938 (LABELING REVISION -- PRECAUTIONS) 17-624 FORANE OHMEDA ISOFLURANE 05-JUL-95 (LIQUID) LIBERTY CORNER, NJ 99.9%...
DDPA May 1996 Drug and Device Product Approvals for May 1996 ***ORIGINAL AND SUPPLEMENTAL NDAs*** FOR NEW DRUG PRODUCTS 16-191 SORBITRATE ZENECA ISOSORBIDE DINITRATE 01-APR-96 (TABLET, SUBLINGUAL) WILMINGTON, DE 2.5MG (SUPPL-033) 19850 5MG (VASODILATOR) [MET CONDITIONS FOR APPROVAL PER FEDERAL REGISTER NOTICE OF AUGUST 3, 1984 (49 FR 31151)] 16-192 SORBITRATE ZENECA ISOSORBIDE DINITRATE 01-APR-96 ...
1996 and Older - New Drug Application (NDA) New Drug Approval Packages These drug approval packages, sorted by product trade name, are supplied by the CDER Freedom of Electronic Information Office
Drug Approval Package: Temovate Ointment 0.05% 19323-S16 FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER - Search - -Drug Review Package Temovate (clobetasol propionate) Ointment, 0.05% Company:- Glaxo Wellcome Inc
Drug Approval Package: Temovate Cream 0.05% 19322-S15 FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER - Search - -Drug Review Package Temovate (clobetasol propionate) Cream, 0.05% Company:- Glaxo Wellcome Inc
Alefacept (Amevive) Clinical Review page 62
author: CBER FDA
subject: dob062703
NDA-I2: NDA Approval Letter page 9
author: SUZANNE CHILDS
subject: NDA Approval Letter - FPL acceptable
NDA-I2: NDA Approval Letter page 7
author: SUZANNE CHILDS
subject: NDA Approval Letter - FPL acceptable
http://www.fda.gov/cder/foi/label/2000/21142lbl.pdf OLUXaeFoam, 0.05% 1 (clobetasol propionate) 2 3 Rx Only 4 For Dermatologic Use Only 5 Not for Ophthalmic Use 6 7 DESCRIPTION 8 OLUX Foam contains clobetasol propionate, USP, a synthetic corticosteroid, for topical 9 dermatologic useClobetasol propionate 19 20 Clobetasol propionate is a white or almost...
http://www.fda.gov/cder/foi/label/2000/21142lbl.pdf page 2
